low-dose CNS-penetrant BACE inhibitor 90% red. of CSF Aβ in Ph. II at 9.2 mg / discont. from opt. vs. CatD and dose red. of prior leads Journal of Medicinal Chemistry Eli Lilly, Indianapolis, US